These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12001868)

  • 1. [Current status of pharmacologic treatment of arrhythmia].
    Cárdenas M
    Arch Cardiol Mex; 2002; 72 Suppl 1():S35-8. PubMed ID: 12001868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic modulation of vulnerable period and the effects of pharmacological treatment of ischemia-induced arrhythmias: a simulation study.
    Cimponeriu A; Starmer CF; Bezerianos A
    IEEE Trans Biomed Eng; 2003 Feb; 50(2):168-77. PubMed ID: 12665030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future of antiarrhythmic drugs.
    Darbar D; Roden DM
    Curr Opin Cardiol; 2006 Jul; 21(4):361-7. PubMed ID: 16755206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
    Semrád B
    Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Respiratory insufficiency and cardiac arrhythmia: the rationale of treatment].
    Sbarbaro G; Parentini GC; Angelinelli PL; Ricci S; Marchioni CF
    Minerva Med; 1993 Jun; 84(6):307-12. PubMed ID: 8336838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model systems for the discovery and development of antiarrhythmic drugs.
    Nattel S; Duker G; Carlsson L
    Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of potassium currents in cardiac arrhythmias.
    Ravens U; Cerbai E
    Europace; 2008 Oct; 10(10):1133-7. PubMed ID: 18653669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anesthesia and cardiac electrophysiology (Part I)].
    Zaballos García M; Almendral Garrote J; Navia Roque J
    Rev Esp Anestesiol Reanim; 2005 May; 52(5):276-89; quiz 289-90, 294. PubMed ID: 15968906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arrhythmia caused by potassium deficiency].
    Motté G
    Arch Mal Coeur Vaiss; 1984 Apr; 77 Spec No():17-22. PubMed ID: 6428359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional, age-dependent, and genotype-dependent differences in ventricular action potential duration and activation time in 410 Langendorff-perfused mouse hearts.
    Waldeyer C; Fabritz L; Fortmueller L; Gerss J; Damke D; Blana A; Laakmann S; Kreienkamp N; Volkery D; Breithardt G; Kirchhof P
    Basic Res Cardiol; 2009 Sep; 104(5):523-33. PubMed ID: 19288151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and new drugs for the treatment of arrhythmias.
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Curr Opin Investig Drugs; 2002 Jul; 3(7):1029-36. PubMed ID: 12186263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary anomalies of ventricular repolarisation].
    Extramiana F; Maison-Blanche P; Haggui A; Milliez P; Cauchemez B; Beaufils P; Leenhardt A
    Arch Mal Coeur Vaiss; 2005 Dec; 98 Spec No 5():21-6. PubMed ID: 16433239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical induction of arrhythmias during ventricular repolarization: modeling cellular mechanisms and their interaction in two dimensions.
    Garny A; Kohl P
    Ann N Y Acad Sci; 2004 May; 1015():133-43. PubMed ID: 15201155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
    Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
    Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The canine virtual ventricular wall: a platform for dissecting pharmacological effects on propagation and arrhythmogenesis.
    Benson AP; Aslanidi OV; Zhang H; Holden AV
    Prog Biophys Mol Biol; 2008; 96(1-3):187-208. PubMed ID: 17915298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From pulsus to pulseless: the saga of cardiac alternans.
    Weiss JN; Karma A; Shiferaw Y; Chen PS; Garfinkel A; Qu Z
    Circ Res; 2006 May; 98(10):1244-53. PubMed ID: 16728670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac conduction and arrhythmia: insights from Nkx2.5 mutations in mouse and humans.
    Jay PY; Berul CI; Tanaka M; Ishii M; Kurachi Y; Izumo S
    Novartis Found Symp; 2003; 250():227-38; discussion 238-41, 276-9. PubMed ID: 12956333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of cellular electrophysiology based on Noble98 dynamic model of ventricular action potential].
    Zhang H; Yang L; Jin Y; Zhang Z; Huang Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Feb; 23(1):6-10. PubMed ID: 16532798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of the frequency of cardiac arrhythmias and conduction disturbances from a health-care perspective].
    Vázquez Ruiz de Castroviejo E; Muñoz Bellido J; Lozano Cabezas C; Ramírez Moreno A; Guzmán Herrera M; Tarabini Castellani A; Fajardo Pineda A; Jiménez Araque B; Armenteros Lechuga JB; Pagola Vilardebó C
    Rev Esp Cardiol; 2005 Jun; 58(6):657-65. PubMed ID: 15970121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.